Dimensional Fund Advisors
CUE icon

Dimensional Fund Advisors’s Cue Biopharma CUE Stock Holding History

Dimensional Fund Advisors’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-486
Closed -$10.9K – 3348
2024
Q3 		$10.9K Sell
486
-6,650
-93% -$144K ﹤0.01% 3346
2024
Q2 		$266K Sell
7,136
-7,241
-50% -$358K ﹤0.01% 3124
2024
Q1 		$815K Sell
14,377
-889
-6% -$62.7K ﹤0.01% 2955
2023
Q4 		$1.21M Sell
15,266
-3,621
-19% -$259K ﹤0.01% 2895
2023
Q3 		$1.3M Buy
18,887
+379
+2% +$37K ﹤0.01% 2864
2023
Q2 		$2.03M Buy
18,508
+321
+2% +$37.7K ﹤0.01% 2780
2023
Q1 		$1.95M Buy
18,187
+2,931
+19% +$280K ﹤0.01% 2748
2022
Q4 		$1.3K Buy
15,256
+117
+0.8% +$10.7K ﹤0.01% 2836
2022
Q3 		$1.01M Sell
15,139
-7,149
-32% -$615K ﹤0.01% 2878
2022
Q2 		$1.67M Sell
22,288
-2,442
-10% -$286K ﹤0.01% 2795
2022
Q1 		$3.62M Sell
24,730
-3,581
-13% -$759K ﹤0.01% 2633
2021
Q4 		$9.61M Buy
28,311
+22,157
+360% +$8.57M ﹤0.01% 2327
2021
Q3 		$2.69M Buy
6,154
+3,463
+129% +$1.21M ﹤0.01% 2756
2021
Q2 		$940K Buy
+2,691
New +$1.04M ﹤0.01% 3039

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Dimensional Fund Advisors's CUE Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of Cue Biopharma (CUE) in Q4 2024, closing a stake of 486 shares — an estimated $10.9K sold.

Dimensional Fund Advisors first reported a position in CUE in Q2 2021 and held it in 14 quarters. The position peaked at $9.61M in Q4 2021. 54 funds tracked by Wall St. Rank hold CUE as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining Cue Biopharma position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 486 Cue Biopharma shares in Q4 2024, an estimated $10.9K.
  • Dimensional Fund Advisors first reported a position in Cue Biopharma in Q2 2021 and held it in 14 quarters.
  • Dimensional Fund Advisors's Cue Biopharma position peaked at $9.61M in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.